Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.5550 (-6.18%) ($4.5550 - $4.5550) on Tue. Sep. 13, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.67% (three month average) | RSI | 59 | Latest Price | $4.5550(-6.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 5.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) SPLV(92%) USO(-34%) UUP(-72%) SDY(82%) SHY(64%) | Factors Impacting ATRA price | ATRA will decline at least -5.335% in a week (0% probabilities). HYG(95%) IWC(87%) IWN(93%) IDRV(91%) BNDX(13%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.335% (StdDev 10.67%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.7(-3.09%) | 10 Day Moving Average | $4.45(2.36%) | 20 Day Moving Average | $4.44(2.59%) | To recent high | -48.1% | To recent low | 59.5% | Market Cap | $338m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |